MarketTwits
249K subscribers
72.8K photos
2.41K videos
1.06K files
75.1K links
Вся информация на канале не является рекомендацией

связь - @MarketTwits_info
связь - info.markettwits@gmail.com
VK - https://vk.com/id635239814

в подборках не участвуем, нигде никогда не рекламируемся, партнерки не практикуем
Download Telegram
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ


#BPMX +73% Biopharmx Corp -after the company announced that its Phase 2b trial of BPX-04 for Populopustular Rosacea met both primary and secondary endpoints and was well tolerated.

#AGN +29% Allergan plc - after AbbVie Inc
#ABBV announced plans To acquire Allergan for $188.24 per share in cash and stock.

#RIOT +16% Riot Blockchain, Inc. - after climbing 10% on Monday.

#IGC +11% India Globalization Capital, Inc. -after surging 25% on Monday.

#JAGX +10% Jaguar Health, Inc.-regained compliance with all applicable Nasdaq Stock Market listing standards.

#SCPH +5% scPharmaceuticals Inc.

#ENDP +5% Endo International plc -after dropping 6% on Monday.

#KRYS +5% Krystal Biotech Inc -priced 2.5 million share public offering of common stock at $40 per share.

#LEN +4% Lennar Corporation -after the company announced better-than-expected results for its second quarter.

#ARQL +4% ArQule, Inc. -priced 9.25 million share offering at $9.75 per share.

#FDS +4% FactSet Research Systems Inc. -after reporting upbeat Q3 results.

#CANF +4% Can-Fite BioPharma Ltd. -after declining 6% on Monday.

#BHC +4% Bausch Health Companies Inc -after the company announced the US launch of DUOBRII lotion 0.01%/0.045% for plaque psoriasis in adults.

#GNFT +3% Genfit SA- after announcing a strategic partnership with Terns Pharmaceuticals to develop and commercialize elafibranor in Greater China. The company will receive an upfront payment of $35 million.

#SBGL +3% Sibanye Gold Limited

#GRUB +3% Grubhub Inc. -Citigroup upgraded GrubHub from Neutral to Buy.

#NBRV +2% Nabriva Therapeutics PLC – ADR -after reporting the EMA validated the marketing authorization application for lufamulin.

ВНИЗ

#CNAT -58% Conatus Pharmaceuticals Inc - after reporting that top-line results from the ENCORE-LF trial of emricasan did not meet the primary endpoint and will discontinue further treatment of patients enrolled.

#ALDX -23% Aldeyra Therapeutics Inc -after the company announced its SOLACE trial in noninfectious anterior uveitis did not achieve statistical significance in its primary or secondary endpoints.

#KERN -11%Akerna Corp. -after dropping 14.09% on Monday.

#IMUX -11% Immunic, Inc. -after rising 90% on Monday.

#GMDA -10% Gamida Cell Ltd -after the company filed for a common stock offering of 4.04 million shares.

#ABBV -9% AbbVie Inc. -after the company announced it will acquire Allergan for $188.24/share.

#BHF -7% Brighthouse Financial, Inc. -Credit Suisse downgraded Brighthouse Financial from Neutral to Underperform and lowered the price target from $35 to $22, while Goldman Sachs downgraded the stock from Neutral to Sell and lowered the price target from $39 to $32.

#MDCO -5% The Medicines Company -after reporting a $150 million common stock offering.

#PVTL -4% Pivotal Software, Inc.

#AMAG -4% AMAG Pharmaceuticals, Inc. -after dropping 4% on Monday.

#BYND -3% Beyond Meat, Inc. - after dropping 8% on Monday.

#SHOP -3% Shopify Inc. -Wedbush downgraded Shopify from Outperform to Neutral.

#NERV -3% Minerva Neurosciences, Inc. -after surging 40% on Monday.
🇺🇸#premarket #сша
премаркет США - акции - заметные движения:

ВВЕРХ
#CBAY +143% CymaBay Therapeutics, Inc. - announced an independent expert panel unanimously concluded there is no evidence of liver injury in the Phase 2b NASH study of seladelpar. The panel supported re-initiating development of seladelpar. The company also reported narrower-than-expected Q1 loss. Raymond James and Evercore ISI Group upgraded CymaBay Therapeutics to Outperform.
#GMDA +89% Gamida Cell Ltd. - reported positive topline data from Phase 3 clinical study of Omidubicel in patients with high-risk hematologic malignancies.
#AOBC +45% American Outdoor Brands Corporation
#NVAX +45% Novavax, Inc. - reported better-than-expected Q1 results. The company also announced it will receive up to $388 million in funding from CEPI for COVID-19 (coronavirus) vaccine development and manufacturing.
#AKRX +39% Akorn, Inc. - following Q1 results. Akorn posted Q1 earnings of $0.36 per share, versus a year-ago loss of $0.10 per share.
#FLNT +32% Fluent, Inc. - following better-than-expected Q1 results.
#IIVI +27% II-VI, Inc. - reported better-than-expected Q3 sales.
#YRCW +26% YRC Worldwide Inc. - reported better-than-expected Q1 results.
#MVIS +25% MicroVision, Inc. - unknown source article from Florida Independent titled 'Microsoft's Acquisition of Microvision Confirmed.'
#NNVC +20% NanoViricides Inc - developed highly effective broad-spectrum drug candidates against coronaviruses.
#CHAP +18% Chaparral Energy, Inc. - following Q1 results. Chaparral Energy reported Q1 EPS of $0.23.
#MGNX +16% MacroGenics, Inc. - after surging over 29% on Monday.
#BHF +14% Brighthouse Financial Inc - reported better-than-expected Q1 earnings.
#IVR +12% Invesco Mortgage Capital Inc. - reported common and preferred stock dividend payment dates.
#IFF +8% International Flavors & Fragrances Inc. - reported better-than-expected Q1 results.
#AMC +7% AMC Entertainment Holdings, Inc. - after jumping around 30% on Monday.
#GO +5% Grocery Outlet Holding Corp - reported better-than-expected Q1 results and comparable store sales up 17.4%.

ВНИЗ
#GJFT -63% Genfit SA - disclosed results from an interim study of RESOLVE-IT Phase 3 trial.
#RAND -32% Rand Capital Corporation - shares climbed 8% on Monday after the company reported Q1 results.
#ADES -25% Advanced Emissions Solutions, Inc. - after reporting Q1 results. Advanced Emissions Solutions posted a Q1 loss of $0.11 per share.
#CRC -23% California Resources Corporation
#NBRV -11% Nabriva Therapeutics plc - reported wider-than-expected Q1 loss.
#EB -11% Eventbrite Inc - reported worse-than-expected Q1 results.
#MRKR -10% Marker Therapeutics, Inc. - following downbeat Q1 earnings. Piper Sandler downgraded Marker Therapeutics from Overweight to Neutral and lowered the price target from $5 to $2.5.
#UAVS -9% AgEagle Aerial Systems, Inc. -after surging around 40% on Monday.
#GNUS -9% Genius Brands International, Inc. - after jumping 39% on Monday.
#DBVT -8% DBV Technologies S.A.
#CPSH -8% CPS Technologies Corporation - after rising around 9% on Monday.
#HALO -7% Halozyme Therapeutics, Inc. - reported worse-than-expected Q1 results.
#AKBA -7% Akebia Therapeutics, Inc. -announced a proposed $100 million public offering of common stock.
#CHEF -6% The Chefs' Warehouse, Inc. - reported a proposed public offering of common stock.
#TME -4% Tencent Music Entertainment Group - ADR -reported worse-than-expected Q1 results.